Login / Signup

C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire.

Ivan KošíkJefferson J S SantosMathew AngelZhe HuJaroslav HollyJames S GibbsTanner GillMartina KosikovaTiansheng LiWilliam BakhachePatrick T DolanHang XieSarah F AndrewsRebecca A GillespieMasaru KanekiyoAdrian B McDermottTheodore C PiersonJonathan W Yewdell
Published in: Science immunology (2024)
Antigenic drift, the gradual accumulation of amino acid substitutions in the influenza virus hemagglutinin (HA) receptor protein, enables viral immune evasion. Antibodies (Abs) specific for the drift-resistant HA stem region are a promising universal influenza vaccine target. Although anti-stem Abs are not believed to block viral attachment, here we show that complement component 1q (C1q), a 460-kilodalton protein with six Ab Fc-binding domains, confers attachment inhibition to anti-stem Abs and enhances their fusion and neuraminidase inhibition. As a result, virus neutralization activity in vitro is boosted up to 30-fold, and in vivo protection from influenza PR8 infection in mice is enhanced. These effects reflect increased steric hindrance and not increased Ab avidity. C1q greatly expands the anti-stem Ab viral escape repertoire to include residues throughout the HA, some of which cause antigenic alterations in the globular region or modulate HA receptor avidity. We also show that C1q enhances the neutralization activity of non-receptor binding domain anti-SARS-CoV-2 spike Abs, an effect dependent on spike density on the virion surface. These findings demonstrate that C1q can greatly expand Ab function and thereby contribute to viral evolution and immune escape.
Keyphrases
  • sars cov
  • binding protein
  • amino acid
  • respiratory syndrome coronavirus
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • protein protein
  • small molecule
  • coronavirus disease